Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4022 clinical trials
featured
PRB244-01: Treatment of Pruritus in Adults With a History of Atopic Dermatitis  

This is a double-blind, randomized, vehicle-controlled study to assess the efficacy, safety, and tolerability of 2 doses of B244 for the treatment of pruritus in adults with a history of

  • 0 views
  • 29 Apr, 2021
  • 1 location
featured
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis  

This study will assess the safety and efficacy of ARQ-151 cream vs vehicle applied once a day for 4 weeks by subjects with atopic dermatitis (eczema).

  • 0 views
  • 13 Apr, 2021
  • 1 location
featured
Study to Evaluate the Safety Tolerability and Efficacy of BGE-175 in Participants 60 Years of Age and Hospitalized With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

The primary objectives of this study are to evaluate the safety, tolerability, and efficacy of BGE-175 in participants 60 years of age hospitalized with documented COVID-19.

  • 0 views
  • 29 Mar, 2021
featured
A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial

A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial

  • 2068 views
  • 23 Nov, 2020
  • 22 locations
featured
A Randomized, Double-Blind, Placebo-Controlled Study of COR388 HCl in Subjects with Alzheimer’s Disease

This is a randomized, double-blind, placebo-controlled study that will assess the efficacy, safety, and tolerability of 2 dose levels of COR388 HCl in subjects with probable

dementia
  • 43 views
  • 08 Dec, 2020
  • 1 location
featured
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of Troriluzole in Generalized Anxiety Disorder

The primary objective of the study is to evaluate the efficacy of troriluzole compared to placebo after 8-weeks of treatment in subjects with GAD, as measured by the Hamilton Anxiety Rating Scale (HAM-A) scale  

  • 383 views
  • 10 May, 2019
  • 1 location
featured
A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

vitiligo
  • 9156 views
  • 15 Dec, 2020
  • 15 locations
featured
A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder

office visits at the study center. Biohaven is also sponsoring a 48-week open-label extension available for those who complete the double-blind portion.

  • 0 views
  • 05 Apr, 2021
  • 1 location
featured
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis  

  • 52 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 2, Double-Blind, Dose-Ranging, Placebo-Controlled Study With Open-Label Extension to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis

double-blind, randomized, placebo-controlled treatment periods followed by 40 weeks open label extension period.  

hematochezia
corticosteroids
endoscopy
azathioprine
mercaptopurine
  • 44 views
  • 23 Nov, 2020
  • 5 locations